An immunotherapy drug called Dostarlimab, tested in a small clinical trial of 14 colorectal cancer patients at Memorial Sloan Kettering Cancer Center, produced unprecedented results: after six months of treatment, all 14 patients, including those with stage 4 cancer, had their tumors completely disappear and the tumors have not returned—the first time complete remission has been achieved in a clinical trial.